APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tafamidis Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tafamidis Drugs Market Analysis and Forecast 2026-2032

Report ID 174039600227 December 2025190 pages

Choose your research edition.

Industry ResearchTafamidis Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Tafamidis Drugs Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Tafamidis Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tafamidis Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tafamidis Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Tafamidis Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tafamidis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tafamidis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tafamidis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tafamidis Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tafamidis Drugs include Pfizer, Qilu pharmaceutical and Chia Tai Tianqing Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tafamidis Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tafamidis Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Tafamidis Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tafamidis Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tafamidis Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tafamidis Drugs sales, projected growth trends, production technology, application and end-user industry.

Tafamidis Drugs Segment by Company

Pfizer

Qilu pharmaceutical

Chia Tai Tianqing Pharmaceutical

Tafamidis Drugs Segment by Type

Tafamidis Free Acid

Tafamidis Meglumine

Tafamidis Drugs Segment by Application

ATTR-PN

ATTR-CM

Other

Tafamidis Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafamidis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tafamidis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafamidis Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tafamidis Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tafamidis Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tafamidis Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tafamidis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tafamidis Free Acid Major Manufacturers Table 3. Tafamidis Meglumine Major Manufacturers Table 4. Global Tafamidis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. ATTR-PN Major Manufacturers Table 6. ATTR-CM Major Manufacturers Table 7. Other Major Manufacturers Table 8. Tafamidis Drugs Industry Trends Table 9. Tafamidis Drugs Industry Drivers Table 10. Tafamidis Drugs Industry Opportunities and Challenges Table 11. Tafamidis Drugs Industry Restraints Table 12. Global Tafamidis Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Tafamidis Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Tafamidis Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Tafamidis Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Tafamidis Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Tafamidis Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Tafamidis Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Tafamidis Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Tafamidis Drugs Sales Market Share by Region (2021-2026) Table 21. Global Tafamidis Drugs Sales Market Share by Region (2027-2032) Table 22. Global Tafamidis Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Tafamidis Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Tafamidis Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Tafamidis Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Tafamidis Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Tafamidis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Tafamidis Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Tafamidis Drugs Manufacturers, Product Type & Application Table 30. Global Tafamidis Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Tafamidis Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Tafamidis Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Tafamidis Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Tafamidis Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Tafamidis Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Tafamidis Drugs Sales Market Share by Type (2021-2026) Table 42. Global Tafamidis Drugs Sales Market Share by Type (2027-2032) Table 43. Global Tafamidis Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Tafamidis Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Tafamidis Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Tafamidis Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Tafamidis Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Tafamidis Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Tafamidis Drugs Sales Market Share by Application (2021-2026) Table 54. Global Tafamidis Drugs Sales Market Share by Application (2027-2032) Table 55. Global Tafamidis Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tafamidis Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Pfizer Company Information Table 58. Pfizer Business Overview Table 59. Pfizer Tafamidis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Pfizer Tafamidis Drugs Product Portfolio Table 61. Pfizer Recent Development Table 62. Qilu pharmaceutical Company Information Table 63. Qilu pharmaceutical Business Overview Table 64. Qilu pharmaceutical Tafamidis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Qilu pharmaceutical Tafamidis Drugs Product Portfolio Table 66. Qilu pharmaceutical Recent Development Table 67. Chia Tai Tianqing Pharmaceutical Company Information Table 68. Chia Tai Tianqing Pharmaceutical Business Overview Table 69. Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolio Table 71. Chia Tai Tianqing Pharmaceutical Recent Development Table 72. North America Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 75. North America Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 76. North America Tafamidis Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Tafamidis Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 81. North America Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 82. North America Tafamidis Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Tafamidis Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Tafamidis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Tafamidis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Tafamidis Drugs Sales by Country (2021-2026) & (K Units) Table 89. North America Tafamidis Drugs Sales by Country (2027-2032) & (K Units) Table 90. North America Tafamidis Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Tafamidis Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 93. Canada Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 94. Mexico Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 95. Europe Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 98. Europe Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 99. Europe Tafamidis Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Tafamidis Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 104. Europe Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 105. Europe Tafamidis Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Tafamidis Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Tafamidis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Tafamidis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Tafamidis Drugs Sales by Country (2021-2026) & (K Units) Table 112. Europe Tafamidis Drugs Sales by Country (2027-2032) & (K Units) Table 113. Europe Tafamidis Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Tafamidis Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 116. France Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 117. U.K. Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 118. Italy Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 119. Russia Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 120. Spain Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 123. Sweden Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 124. Poland Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 125. China Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 126. China Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 127. China Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 128. China Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 129. China Tafamidis Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Tafamidis Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 132. China Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 133. China Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 134. China Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 135. China Tafamidis Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Tafamidis Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 140. Asia Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 141. Asia Tafamidis Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Tafamidis Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 146. Asia Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 147. Asia Tafamidis Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Tafamidis Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Tafamidis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Tafamidis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Tafamidis Drugs Sales by Country (2021-2026) & (K Units) Table 154. Asia Tafamidis Drugs Sales by Country (2027-2032) & (K Units) Table 155. Asia Tafamidis Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Tafamidis Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 158. South Korea Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 159. India Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 160. Australia Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Tafamidis Drugs Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Tafamidis Drugs Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Tafamidis Drugs Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Tafamidis Drugs Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Tafamidis Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Tafamidis Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Tafamidis Drugs Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Tafamidis Drugs Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Tafamidis Drugs Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Tafamidis Drugs Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Tafamidis Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Tafamidis Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Tafamidis Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Tafamidis Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Tafamidis Drugs Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Tafamidis Drugs Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Tafamidis Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Tafamidis Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 184. Argentina Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 185. Chile Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 186. Colombia Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 187. Peru Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 189. Israel Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 190. UAE Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 191. Turkey Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 192. Iran Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 193. Egypt Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Tafamidis Drugs Distributors List Table 197. Tafamidis Drugs Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Tafamidis Drugs Image Figure 2. Global Tafamidis Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tafamidis Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tafamidis Free Acid Image Figure 5. Tafamidis Meglumine Image Figure 6. Global Tafamidis Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tafamidis Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. ATTR-PN Image Figure 9. ATTR-CM Image Figure 10. Other Image Figure 11. Global Tafamidis Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Tafamidis Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Tafamidis Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Tafamidis Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Tafamidis Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Tafamidis Drugs Sales (2021-2032) & (K Units) Figure 17. Global Tafamidis Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Tafamidis Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Tafamidis Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Tafamidis Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Tafamidis Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Tafamidis Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Tafamidis Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Tafamidis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Tafamidis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Tafamidis Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Tafamidis Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Tafamidis Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Tafamidis Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Tafamidis Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Tafamidis Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Tafamidis Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Tafamidis Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Tafamidis Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Tafamidis Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Tafamidis Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Tafamidis Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Tafamidis Drugs Revenue Share by Type (2021-2032) Figure 40. North America Tafamidis Drugs Sales Share by Type (2021-2032) Figure 41. North America Tafamidis Drugs Revenue Share by Application (2021-2032) Figure 42. North America Tafamidis Drugs Sales Share by Application (2021-2032) Figure 43. North America Tafamidis Drugs Revenue Share by Country (2021-2032) Figure 44. North America Tafamidis Drugs Sales Share by Country (2021-2032) Figure 45. Europe Tafamidis Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Tafamidis Drugs Sales Share by Type (2021-2032) Figure 47. Europe Tafamidis Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Tafamidis Drugs Sales Share by Application (2021-2032) Figure 49. Europe Tafamidis Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Tafamidis Drugs Sales Share by Country (2021-2032) Figure 51. China Tafamidis Drugs Revenue Share by Type (2021-2032) Figure 52. China Tafamidis Drugs Sales Share by Type (2021-2032) Figure 53. China Tafamidis Drugs Revenue Share by Application (2021-2032) Figure 54. China Tafamidis Drugs Sales Share by Application (2021-2032) Figure 55. Asia Tafamidis Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Tafamidis Drugs Sales Share by Type (2021-2032) Figure 57. Asia Tafamidis Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Tafamidis Drugs Sales Share by Application (2021-2032) Figure 59. Asia Tafamidis Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Tafamidis Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Tafamidis Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Tafamidis Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Tafamidis Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Tafamidis Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Tafamidis Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Tafamidis Drugs Sales Share by Country (2021-2032) Figure 67. Tafamidis Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tafamidis Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tafamidis Free Acid
  • Tafamidis Meglumine
Applications
  • ATTR-PN
  • ATTR-CM
  • Other
Companies covered
  • Pfizer
  • Qilu pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tafamidis Drugs Market by Type
  3. 1.2.1 Global Tafamidis Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tafamidis Free Acid
  5. 1.2.3 Tafamidis Meglumine
  6. 1.3 Tafamidis Drugs Market by Application
  7. 1.3.1 Global Tafamidis Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 ATTR-PN
  9. 1.3.3 ATTR-CM
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Tafamidis Drugs Market Dynamics
  1. 2.1 Tafamidis Drugs Industry Trends
  2. 2.2 Tafamidis Drugs Industry Drivers
  3. 2.3 Tafamidis Drugs Industry Opportunities and Challenges
  4. 2.4 Tafamidis Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tafamidis Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tafamidis Drugs Revenue by Region
  3. 3.2.1 Global Tafamidis Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tafamidis Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Tafamidis Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Tafamidis Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tafamidis Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tafamidis Drugs Sales by Region
  9. 3.4.1 Global Tafamidis Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tafamidis Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Tafamidis Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Tafamidis Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tafamidis Drugs Revenue by Manufacturers
  2. 4.1.1 Global Tafamidis Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tafamidis Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tafamidis Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tafamidis Drugs Sales by Manufacturers
  6. 4.2.1 Global Tafamidis Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tafamidis Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tafamidis Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tafamidis Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tafamidis Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tafamidis Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tafamidis Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Tafamidis Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tafamidis Drugs Market CR5 and HHI
  16. 4.8.2 2025 Tafamidis Drugs Tier 1, Tier 2, and Tier 3
5 Tafamidis Drugs Market by Type
  1. 5.1 Global Tafamidis Drugs Revenue by Type
  2. 5.1.1 Global Tafamidis Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tafamidis Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tafamidis Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tafamidis Drugs Sales by Type
  6. 5.2.1 Global Tafamidis Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tafamidis Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Tafamidis Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tafamidis Drugs Price by Type
6 Tafamidis Drugs Market by Application
  1. 6.1 Global Tafamidis Drugs Revenue by Application
  2. 6.1.1 Global Tafamidis Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tafamidis Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tafamidis Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tafamidis Drugs Sales by Application
  6. 6.2.1 Global Tafamidis Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tafamidis Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Tafamidis Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tafamidis Drugs Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Tafamidis Drugs Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Qilu pharmaceutical
  8. 7.2.1 Qilu pharmaceutical Company Information
  9. 7.2.2 Qilu pharmaceutical Business Overview
  10. 7.2.3 Qilu pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qilu pharmaceutical Tafamidis Drugs Product Portfolio
  12. 7.2.5 Qilu pharmaceutical Recent Developments
  13. 7.3 Chia Tai Tianqing Pharmaceutical
  14. 7.3.1 Chia Tai Tianqing Pharmaceutical Company Information
  15. 7.3.2 Chia Tai Tianqing Pharmaceutical Business Overview
  16. 7.3.3 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chia Tai Tianqing Pharmaceutical Tafamidis Drugs Product Portfolio
  18. 7.3.5 Chia Tai Tianqing Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Tafamidis Drugs Market Size by Type
  2. 8.1.1 North America Tafamidis Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Tafamidis Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Tafamidis Drugs Price by Type (2021-2032)
  5. 8.2 North America Tafamidis Drugs Market Size by Application
  6. 8.2.1 North America Tafamidis Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Tafamidis Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Tafamidis Drugs Price by Application (2021-2032)
  9. 8.3 North America Tafamidis Drugs Market Size by Country
  10. 8.3.1 North America Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tafamidis Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tafamidis Drugs Market Size by Type
  2. 9.1.1 Europe Tafamidis Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tafamidis Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Tafamidis Drugs Price by Type (2021-2032)
  5. 9.2 Europe Tafamidis Drugs Market Size by Application
  6. 9.2.1 Europe Tafamidis Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tafamidis Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Tafamidis Drugs Price by Application (2021-2032)
  9. 9.3 Europe Tafamidis Drugs Market Size by Country
  10. 9.3.1 Europe Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tafamidis Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tafamidis Drugs Market Size by Type
  2. 10.1.1 China Tafamidis Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Tafamidis Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Tafamidis Drugs Price by Type (2021-2032)
  5. 10.2 China Tafamidis Drugs Market Size by Application
  6. 10.2.1 China Tafamidis Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Tafamidis Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Tafamidis Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tafamidis Drugs Market Size by Type
  2. 11.1.1 Asia Tafamidis Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tafamidis Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Tafamidis Drugs Price by Type (2021-2032)
  5. 11.2 Asia Tafamidis Drugs Market Size by Application
  6. 11.2.1 Asia Tafamidis Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tafamidis Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Tafamidis Drugs Price by Application (2021-2032)
  9. 11.3 Asia Tafamidis Drugs Market Size by Country
  10. 11.3.1 Asia Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tafamidis Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tafamidis Drugs Market Size by Type
  2. 12.1.1 SAMEA Tafamidis Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tafamidis Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tafamidis Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Tafamidis Drugs Market Size by Application
  6. 12.2.1 SAMEA Tafamidis Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tafamidis Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tafamidis Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Tafamidis Drugs Market Size by Country
  10. 12.3.1 SAMEA Tafamidis Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tafamidis Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tafamidis Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tafamidis Drugs Value Chain Analysis
  2. 13.1.1 Tafamidis Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tafamidis Drugs Production Mode & Process
  6. 13.2 Tafamidis Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tafamidis Drugs Distributors
  9. 13.2.3 Tafamidis Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst